I agree. I'm Looking forward to the DFU results and it will be interesting to see how stem cells compare with soft tissue compared to cartlidge regeration.
If we can get some positive results from the DFU and management can cut some sort of deal without giving away the company, maybe there will be some light at the end of the tunnel.
Ann: Phase 3 Osteoarthritis Clinical Trial Commences, page-394
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.010(3.57%) |
Mkt cap ! $52.09M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 29.0¢ | 27.0¢ | $8.285K | 29.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35573 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 16184 | 1 |
View Market Depth
| Last trade - 15.57pm 27/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |